palmidrol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisogno, T | 1 |
| Martire, A | 1 |
| Petrosino, S | 1 |
| Popoli, P | 1 |
| Di Marzo, V | 1 |
1 other study available for palmidrol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
Topics: Amides; Animals; Brain; Cannabinoid Receptor Modulators; Disease Models, Animal; Endocannabinoids; E | 2008 |